Added Value of Liver MRI in Patients Eligible for Surgical Resection or Ablation of Colorectal Liver Metastases Based on CT: A Systematic Review and Meta-Analysis

Abdominal computed tomography (CT) is the standard imaging modality for detection and staging in patients with colorectal liver metastases (CRLM). Although liver magnetic resonance imaging (MRI) is superior to CT in detecting small lesions, guidelines are ambiguous regarding the added value of an additional liver MRI in the surgical workup of patients with CRLM. Therefore, this systematic review and meta-analysis aimed to evaluate the clinical added value of liver MRI in patients eligible for resection or ablation of CRLM based on CT. A systematic search was performed in the PubMed, Embase, and Cochrane Library databases through June 23, 2023. Studies investigating the impact of additional MRI on local treatment plan following CT in patients with CRLM were included. Risk of bias was assessed using the QUADAS-2 tool. The pooled weighted proportions for the primary outcome were calculated using random effect meta-analysis. Overall, 11 studies with 1440 patients were included, of whom 468 patients (32.5%) were assessed for change in local treatment plan. Contrast-enhanced liver MRI was used in 10 studies, including gadoxetic acid in 9 studies. Liver MRI with diffusion-weighted imaging was used in 8 studies. Pooling of data found a 24.12% (95% confidence interval, 15.58%–32.65%) change in the local treatment plan based on the added findings of liver MRI following CT. Sensitivity analysis including 5 studies (268 patients) focusing on monophasic portal venous CT followed by gadoxetic acid-enhanced liver MRI with diffusion-weighted imaging showed a change of local treatment plan of 17.88% (95% confidence interval, 5.14%–30.62%). This systematic review and meta-analysis found that liver MRI changed the preinterventional local treatment plan in approximately one-fifth of patients eligible for surgical resection or ablation of CRLM based on CT. These findings suggest a clinically relevant added value of routine liver MRI in the preinterventional workup of CRLM, which should be confirmed by large prospective studies.

[1]  J. Rübenthaler,et al.  Economic evaluation of 18F-FDG PET/CT, MRI and CE-CT in selection of colorectal liver metastases eligible for ablation - A cost-effectiveness analysis. , 2023, European journal of radiology.

[2]  N. Normanno,et al.  Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  D. Volterrani,et al.  Impact of baseline gadoxetic acid-enhanced liver magnetic resonance and diffusion-weighted imaging in resectable colorectal liver metastases: A prospective, monocentric study. , 2022, Surgical oncology.

[4]  P. Bossuyt,et al.  Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study , 2021, BMC Cancer.

[5]  Pengfei Xu,et al.  Global colorectal cancer burden in 2020 and projections to 2040 , 2021, Translational oncology.

[6]  P. Karanicolas,et al.  When is a Ghost Really Gone? A Systematic Review and Meta-analysis of the Accuracy of Imaging Modalities to Predict Complete Pathological Response of Colorectal Cancer Liver Metastases After Chemotherapy , 2021, Annals of Surgical Oncology.

[7]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[8]  E. Nakakura,et al.  Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era. , 2020, The Journal of surgical research.

[9]  N. Russolillo,et al.  Comparison of laparoscopic ultrasound and liver-specific magnetic resonance imaging for staging colorectal liver metastases , 2020, Surgical Endoscopy.

[10]  M. Argyropoulou,et al.  Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis , 2020, Acta radiologica.

[11]  M. den Dulk,et al.  Preoperative imaging for colorectal liver metastases: a nationwide population‐based study , 2020, BJS open.

[12]  F. Giuliante,et al.  Intraoperative Ultrasound Staging for Colorectal Liver Metastases in the Era of Liver-Specific Magnetic Resonance Imaging: Is It Still Worthwhile? , 2019, Journal of oncology.

[13]  N. Abolmaali,et al.  Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases , 2019, Journal of surgical oncology.

[14]  Y. Puckett,et al.  Literature Review of Current Management of Colorectal Liver Metastasis , 2019, Cureus.

[15]  A. L. Vahrmeijer,et al.  Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases , 2018, BMC Medical Imaging.

[16]  O. Farges,et al.  Half of Postoperative Deaths After Hepatectomy may be Preventable: A Root-cause Analysis of a Prospective Multicenter Cohort Study , 2018, Annals of surgery.

[17]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[18]  M. Coolsen,et al.  Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial , 2018, BMC Cancer.

[19]  K. Tan,et al.  Prospective comparison between magnetic resonance imaging and computed tomography in colorectal cancer staging , 2018, ANZ journal of surgery.

[20]  S. Park,et al.  Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer , 2018, European Radiology.

[21]  C. Moulton,et al.  Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan. , 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[22]  Duck-Woo Kim,et al.  Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer? , 2017, Diseases of the colon and rectum.

[23]  G. Maddern,et al.  Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: a systematic review and meta-analysis , 2016, International Journal of Colorectal Disease.

[24]  A. Schulz,et al.  Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI , 2016, Acta radiologica.

[25]  Myeong-Jin Kim,et al.  Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial , 2016, European Radiology.

[26]  Christophe Aubé,et al.  A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases , 2016, European Radiology.

[27]  J. Rosenberg,et al.  Preoperative CT versus diffusion weighted magnetic resonance imaging of the liver in patients with rectal cancer; a prospective randomized trial , 2016, PeerJ.

[28]  A. Saiura,et al.  Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis , 2015, Annals of surgery.

[29]  L. Påhlman,et al.  Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2015, Cancer treatment reviews.

[30]  M. Imbriaco,et al.  Non-invasive diagnostic imaging of colorectal liver metastases. , 2015, World journal of radiology.

[31]  M. Koopman,et al.  Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases , 2015, Clinical & Experimental Metastasis.

[32]  S. Park,et al.  Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. , 2015, Radiology.

[33]  K. Jong,et al.  Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands , 2015, International Journal of Colorectal Disease.

[34]  Yoo-Seok Yoon,et al.  Role of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in the Preoperative Evaluation of Small Hepatic Lesions in Patients with Colorectal Cancer , 2015, World Journal of Surgery.

[35]  A. Shinagare,et al.  Update on the role of imaging in management of metastatic colorectal cancer. , 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

[36]  D. Jeyarajah,et al.  MRI with Gadoxetate Disodium for Colorectal Liver Metastasis: Is It the New “Imaging Modality of Choice”? , 2014, Journal of Gastrointestinal Surgery.

[37]  R. Golfieri,et al.  Imaging in resectable colorectal liver metastasis patients with or without preoperative chemotherapy: results of the PROMETEO-01 study , 2014, British Journal of Cancer.

[38]  T. Murakami,et al.  Does Gadoxetic acid-enhanced 3.0T MRI in addition to 64-detector-row contrast-enhanced CT provide better diagnostic performance and change the therapeutic strategy for the preoperative evaluation of colorectal liver metastases? , 2014, European Radiology.

[39]  Myeong-Jin Kim,et al.  Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases , 2014, The British journal of surgery.

[40]  Luigia D'Errico,et al.  Colorectal cancer: current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation. , 2013, World journal of gastroenterology.

[41]  Lihua Chen,et al.  Meta-Analysis of Gadoxetic Acid Disodium (Gd-EOB-DTPA)-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases , 2012, PloS one.

[42]  K. Chandrakumaran,et al.  Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[43]  T. Gruenberger,et al.  Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI? , 2011, European journal of radiology.

[44]  J. Stoker,et al.  Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. , 2010, Radiology.

[45]  V. Torri,et al.  Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis , 2010, Journal of magnetic resonance imaging : JMRI.

[46]  A. Zwinderman,et al.  Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. , 2005, Radiology.

[47]  Harmeet Kaur,et al.  ACR Appropriateness Criteria® Pretreatment Staging of Colorectal Cancer. , 2017, Journal of the American College of Radiology : JACR.

[48]  小島原典子,et al.  診断精度研究のバイアスリスク評価ツールQUADAS－2：a Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies 2 の活用 , 2014 .